The relation of vitamin D with immune system, skin and cancer.

Year 2013, Volume: 20 Issue: 4, 158 - 161, 30.12.2013

Mehtap Kıdır

Abstract

The relation of vitamin D with immune system, skin and cancer.In humans, approximately 95% of the total requirement for vitamin D is synthesized in the skin by the effectsof sunlight. The active vitamin D synthesis from 25 (OH) D takes place via the 1-alpha hydroxylase enzymeboth in renal and non-renal tissues. The effect of vitamin D on the receptor level is through active vitaminD. Vitamin D receptors are shown in more than 30 tissues. Non-classical effects of vitamin D are groupedunder three main headings: Regulation of hormone secretion, regulation of immune function, regulation ofcell proliferation and differentiation. The relationship immune system, skin diseases cancer and vitamin Dis the most widely researched topics

Keywords

Vitamin D, immune system, skin, cancer

D VİTAMİNİNİN İMMÜN SİSTEM, DERİ VE KANSER İLE İLİŞKİSİ

Abstract

İnsanlarda D vitamini ihtiyacının yaklaşık % 95'i güneş ışınlarının etkisiyle deride sentezlenmektedir. Böbrek dışı dokularda da 1-alfa hidroksilaz enzimi aracılığıyla aktif vitamin D sentezi gerçekleşmektedir. D vitamininin reseptör düzeyindeki etkisi aktif vitamin D sayesinde olur. Otuzdan fazla dokuda vitamin D reseptörleri gösterilmiştir. Vitamin D'nin iskelet sistemi dışındaki etkileri 3 ana başlık altında toplanmaktadır: Hormon sekresyonunun regülasyonu, immün fonksiyonların regülasyonu, hücre proliferasyon ve farklılaşmasının düzenlenmesi. İmmun sistem, cilt hastalıkları, kanser vitamin D ile ilişkisi en çok araştırılan konular arasındadır.
Anahtar Kelimeler: D vitamini; kemik dışı etkiler; immün sistem; deri; kanser
SUMMARY
In humans, approximately 95% of the total requirement for vitamin D is synthesized in the skin by the effects of sunlight. The active vitamin D synthesis from 25 (OH) D takes place via the 1-alpha hydroxylase enzyme both in renal and non-renal tissues. The effect of vitamin D on the receptor level is through active vitamin D. Vitamin D receptors are shown in more than 30 tissues. Non-classical effects of vitamin D are grouped under three main headings: Regulation of hormone secretion, regulation of immune function, regulation of cell proliferation and differentiation. The relationship immune system, skin diseases and cancer between vitamin D is the most widely researched topics.
Key words: Vitamin D; nonskeletal effects; immune system; skin; cancer

Keywords

D vitamini, immün sistem, deri, kanser

References

• 1 . Bikle D. Nonclassic Actions of Vitamin D. J Clin Endocrinol Metab 2009; 94(1): 26–34
• 2 . Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, et al. The Nonskeletal Effects of Vitamin D: An Endocrine Society Scientific Statement. Endocrine Reviews 2012; 33(3): 456–492
• 3 . Özkan B, Döneray H. D vitamininin iskelet sistemi dýþý etkileri. Çocuk Saðlýðý ve Hastalýklarý Dergisi 2011; 54: 99-119
• 4 . Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007; 179: 1634–1647
• 5 . Penna G, Adorini L. 1a,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000; 164: 2405–2411
• 6 . Adorini L. Intervention in autoimmunity: the potential of vitamin D receptor agonists. Cell Immunol 2005; 233: 115–124
• 7 . Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J 2001; 15: 2579–2585
• 8 . Ponsonby AL, McMichael A, van der Mei I. Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 2002; 181–182: 71–78
• 9 . Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001; 358: 1500–1503
• 1 0 . Bikle DD, Oda Y, Xie Z. Calcium and 1,25(OH)2D: interacting drivers of epidermal differentiation. J Steroid Biochem Mol Biol 2004; 89–90: 355–360
• 11 . Skorija K, Cox M, Sisk JM, Dowd DR, MacDonald PN, Thompson CC, et al. Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Mol Endocrinol 2005; 19: 855–862
• 1 2 . Xie Z, Komuves L, Yu QC, Elalieh H, Ng DC, Leary C, et al. Lack of the vitamin D receptor is associated with reduced epidermal differentiation and hair follicle growth. J Invest Dermatol 2002; 118: 11–16
• 1 3 . Ozkan B. Nutritional rickets. J Clin Res Pediatr Endocrinol 2010; 4: 137-143.
• 1 4 . Holick MF. Vitamin D: extraskeletal health. Endocrinol Metab Clin North Am 2010; 39: 381-400.
• 1 5 . Teichert AE, Elalieh H, Elias PM, Welsh J, Bikle DD. Overexpression of hedgehog signaling is associated with epidermal tumor formation in vitamin D receptor null mice. J Invest Dermatol 2011; 131: 2289–2297
• 1 6 . Ellison TI, Smith MK, Gilliam AC, MacDonald PN. Inactivation of the vitamin D receptor enhances susceptibility of murine skin to UV-induced tumorigenesis. J Invest Dermatol 2008; 128: 2508–2517
• 1 7 . Zinser GM, Sundberg JP, Welsh J. Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis. Carcinogenesis 2002; 23: 2103–2109
• 1 8 . Manson JE, Mayne ST, Clinton SK. Vitamin D and prevention of cancer—ready for prime time? (perspective). N Engl J Med 2011; 364: 1385–1387
• 1 9 . Krishnan AV, Feldman D. Mechanisms of the anticancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol 2011; 51: 311–336
• 2 0 . Deeb KK, Trump DL, Johnson CS. Vitamin D signaling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 2007; 7: 684–700
• 2 1 .Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the
• Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96: 53–58
• 2 2 . Trivedi DP, Doll R, Khaw KT. Effect of four-monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003; 326: 469
• 2 3 . Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85: 1586–1591
• 2 4 . Gross C, Stamey T, Hancock S, Feldman D. Treatment of early recurrent prostate cancer with 1,25- dihydroxyvitamin D3 (calcitriol). J Urol 1998; 159: 2035–2039; discussion 2039–2040
• 2 5 . Rossi M, McLaughlin JK, Lagiou P, Bosetti C, Talamini R, Lipworth L, et al. Vitamin D intake and breast cancer risk: a case-control study in Italy. Ann Oncol 2009; 20: 374–378
• 2 6 . Anderson LN, Cotterchio M, Vieth R, Knight JA. Vitamin D and calcium intakes and breast cancer risk in pre- and postmenopausal women. Am J Clin Nutr 2010; 91: 1699–1707
• 2 7 . Tangpricha V, Spina C, Yao M, Chen TC, Wolfe MM, Holick MF. Vitamin D deficiency enhances the growth of MC-26 colon cancer xenografts in Balb/c mice. J Nutr 2005; 135: 2350–2354
• 2 8 . Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S. Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective Study. Br J Cancer 2007; 97: 446-451
• 2 9 . Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta- analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2011; 155: 827–838
• 3 0 . Washington MN, Weigel NL. 1a,25-Dihydroxyvitamin D3 inhibits growth of VCaP prostate cancer cells despite inducing the growth-promoting TMPRSS2:ERG gene fusion. Endocrinology 2010; 151: 1409–1417
• 3 1 . Helzlsouer KJ, VDPP Steering Committee. Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010; 172: 4–9